Dry Needling and Muscle Stiffness

Muscle Tightness Clinical Trial

Official title:

Effect of Intramuscular Dry Needling on Soft Tissue Stiffness and Pressure-pain Thresholds

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05538598
• Other study ID #: H22-01852
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2022
• Est. completion date: September 2023

Study information

• Verified date: December 2022
• Source: University of British Columbia
• Contact: Michael Koehle, MD, PhD
• Phone: 604 822 9331
• Email: michael.koehle[@]ubc.ca
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to investigate the effect of intramuscular dry needling (IMDN) on muscle stiffness and pain. Research has suggested that IMDN can reduce muscle stiffness in needled areas. As well, IMDN may reduce mechanical pain sensitivity experienced by individuals. IMDN will be performed at several anatomical locations. Muscle stiffness will be measured with a handheld probe, which measures contact force and displacement of soft tissue. Pressure-pain thresholds (PPT) will be discovered at each region of interest. Stiffness and pressure-pain thresholds will be collected before and after IMDN. The data collected from this research is important to understand the mechanism of IMDN and its relationship to pain.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 28
• Est. completion date: September 2023
• Est. primary completion date: September 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• over the age of 18
• pain-free in your lower back and lower legs

Exclusion Criteria:

• unable to communicate in English
• surgery of any kind in the lumbar spine or lower legs.
• participants with a skin condition that does not allow for hypoallergenic tape to be attached to their skin.
• have a BMI>25
• unable to hold your breath for 20 seconds
• contraindications to dry needling, i.e. pregnancy; fever or infection that is in your bloodstream; unstable compromised immune system; unstable bleeding disorders; presence at the site of DN of infection, an open wound , a burn, cellulitis, or an undiagnosed lump; post- mastectomy/lymph node removal in the affected limb; post-major surgery (3-6 month time period); presence of metal or plastic implant; absent sensation in area of planned DN; post-bacterial endocarditis or heart valve conditions/replacement without medical clearance for DN from medical doctor.

Related Conditions & MeSH terms

• Muscle Tightness

Intervention

Procedure:
• Intramuscular Dry Needling
The insertion of thin monofilament needles (without injectate) into a tight band of muscle. The needles will be inserted into the muscle for ~10 seconds.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Effective stiffness of soft tissue	Force-displacement data is collected while deforming the soft tissue at the skin surface with a non-invasive handheld probe. The effective stiffness is a summary of the deformation behavior of the soft tissue. It is estimated using the force-displacement data as an input to the incompressible isotropic hyperelastic Ogden model. A higher value indicates that the soft tissue is stiffer than a lower value.	Within 10 minutes of intervention
Primary	Pressure-pain threshold	The measured pressure at the moment the perception of pressure turns into pain	Within 10 minutes of intervention